Chapter/Section Purchase

1 Introduction to Research & Analysis Reports
1.1 Subcutaneous Biologics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Subcutaneous Biologics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Subcutaneous Biologics Overall Market Size
2.1 Global Subcutaneous Biologics Market Size: 2021 VS 2028
2.2 Global Subcutaneous Biologics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Subcutaneous Biologics Players in Global Market
3.2 Top Global Subcutaneous Biologics Companies Ranked by Revenue
3.3 Global Subcutaneous Biologics Revenue by Companies
3.4 Top 3 and Top 5 Subcutaneous Biologics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Subcutaneous Biologics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Subcutaneous Biologics Players in Global Market
3.6.1 List of Global Tier 1 Subcutaneous Biologics Companies
3.6.2 List of Global Tier 2 and Tier 3 Subcutaneous Biologics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Subcutaneous Biologics Market Size Markets, 2021 & 2028
4.1.2 Syringe
4.1.3 Wearable injector
4.1.4 Automatic injector
4.1.5 Implants
4.2 By Type - Global Subcutaneous Biologics Revenue & Forecasts
4.2.1 By Type - Global Subcutaneous Biologics Revenue, 2017-2022
4.2.2 By Type - Global Subcutaneous Biologics Revenue, 2023-2028
4.2.3 By Type - Global Subcutaneous Biologics Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Subcutaneous Biologics Market Size, 2021 & 2028
5.1.2 Hospital pharmacies
5.1.3 Retail pharmacies
5.1.4 Drug stores
5.1.5 Online pharmacies
5.2 By Application - Global Subcutaneous Biologics Revenue & Forecasts
5.2.1 By Application - Global Subcutaneous Biologics Revenue, 2017-2022
5.2.2 By Application - Global Subcutaneous Biologics Revenue, 2023-2028
5.2.3 By Application - Global Subcutaneous Biologics Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Subcutaneous Biologics Market Size, 2021 & 2028
6.2 By Region - Global Subcutaneous Biologics Revenue & Forecasts
6.2.1 By Region - Global Subcutaneous Biologics Revenue, 2017-2022
6.2.2 By Region - Global Subcutaneous Biologics Revenue, 2023-2028
6.2.3 By Region - Global Subcutaneous Biologics Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Subcutaneous Biologics Revenue, 2017-2028
6.3.2 US Subcutaneous Biologics Market Size, 2017-2028
6.3.3 Canada Subcutaneous Biologics Market Size, 2017-2028
6.3.4 Mexico Subcutaneous Biologics Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Subcutaneous Biologics Revenue, 2017-2028
6.4.2 Germany Subcutaneous Biologics Market Size, 2017-2028
6.4.3 France Subcutaneous Biologics Market Size, 2017-2028
6.4.4 U.K. Subcutaneous Biologics Market Size, 2017-2028
6.4.5 Italy Subcutaneous Biologics Market Size, 2017-2028
6.4.6 Russia Subcutaneous Biologics Market Size, 2017-2028
6.4.7 Nordic Countries Subcutaneous Biologics Market Size, 2017-2028
6.4.8 Benelux Subcutaneous Biologics Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Subcutaneous Biologics Revenue, 2017-2028
6.5.2 China Subcutaneous Biologics Market Size, 2017-2028
6.5.3 Japan Subcutaneous Biologics Market Size, 2017-2028
6.5.4 South Korea Subcutaneous Biologics Market Size, 2017-2028
6.5.5 Southeast Asia Subcutaneous Biologics Market Size, 2017-2028
6.5.6 India Subcutaneous Biologics Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Subcutaneous Biologics Revenue, 2017-2028
6.6.2 Brazil Subcutaneous Biologics Market Size, 2017-2028
6.6.3 Argentina Subcutaneous Biologics Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Subcutaneous Biologics Revenue, 2017-2028
6.7.2 Turkey Subcutaneous Biologics Market Size, 2017-2028
6.7.3 Israel Subcutaneous Biologics Market Size, 2017-2028
6.7.4 Saudi Arabia Subcutaneous Biologics Market Size, 2017-2028
6.7.5 UAE Subcutaneous Biologics Market Size, 2017-2028
7 Players Profiles
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Corporate Summary
7.1.2 Abbott Laboratories Business Overview
7.1.3 Abbott Laboratories Subcutaneous Biologics Major Product Offerings
7.1.4 Abbott Laboratories Subcutaneous Biologics Revenue in Global Market (2017-2022)
7.1.5 Abbott Laboratories Key News
7.2 Pfizer Inc.
7.2.1 Pfizer Inc. Corporate Summary
7.2.2 Pfizer Inc. Business Overview
7.2.3 Pfizer Inc. Subcutaneous Biologics Major Product Offerings
7.2.4 Pfizer Inc. Subcutaneous Biologics Revenue in Global Market (2017-2022)
7.2.5 Pfizer Inc. Key News
7.3 Genentech Inc.
7.3.1 Genentech Inc. Corporate Summary
7.3.2 Genentech Inc. Business Overview
7.3.3 Genentech Inc. Subcutaneous Biologics Major Product Offerings
7.3.4 Genentech Inc. Subcutaneous Biologics Revenue in Global Market (2017-2022)
7.3.5 Genentech Inc. Key News
7.4 Novartis AG
7.4.1 Novartis AG Corporate Summary
7.4.2 Novartis AG Business Overview
7.4.3 Novartis AG Subcutaneous Biologics Major Product Offerings
7.4.4 Novartis AG Subcutaneous Biologics Revenue in Global Market (2017-2022)
7.4.5 Novartis AG Key News
7.5 Biogen Idec
7.5.1 Biogen Idec Corporate Summary
7.5.2 Biogen Idec Business Overview
7.5.3 Biogen Idec Subcutaneous Biologics Major Product Offerings
7.5.4 Biogen Idec Subcutaneous Biologics Revenue in Global Market (2017-2022)
7.5.5 Biogen Idec Key News
7.6 AbbVie Inc.
7.6.1 AbbVie Inc. Corporate Summary
7.6.2 AbbVie Inc. Business Overview
7.6.3 AbbVie Inc. Subcutaneous Biologics Major Product Offerings
7.6.4 AbbVie Inc. Subcutaneous Biologics Revenue in Global Market (2017-2022)
7.6.5 AbbVie Inc. Key News
7.7 F. Hoffmann-La Roche AG
7.7.1 F. Hoffmann-La Roche AG Corporate Summary
7.7.2 F. Hoffmann-La Roche AG Business Overview
7.7.3 F. Hoffmann-La Roche AG Subcutaneous Biologics Major Product Offerings
7.7.4 F. Hoffmann-La Roche AG Subcutaneous Biologics Revenue in Global Market (2017-2022)
7.7.5 F. Hoffmann-La Roche AG Key News
7.8 Bristol-Myers Squibb
7.8.1 Bristol-Myers Squibb Corporate Summary
7.8.2 Bristol-Myers Squibb Business Overview
7.8.3 Bristol-Myers Squibb Subcutaneous Biologics Major Product Offerings
7.8.4 Bristol-Myers Squibb Subcutaneous Biologics Revenue in Global Market (2017-2022)
7.8.5 Bristol-Myers Squibb Key News
7.9 Eisai Inc.
7.9.1 Eisai Inc. Corporate Summary
7.9.2 Eisai Inc. Business Overview
7.9.3 Eisai Inc. Subcutaneous Biologics Major Product Offerings
7.9.4 Eisai Inc. Subcutaneous Biologics Revenue in Global Market (2017-2022)
7.9.5 Eisai Inc. Key News
7.10 Takeda Pharmaceuticals Ltd.
7.10.1 Takeda Pharmaceuticals Ltd. Corporate Summary
7.10.2 Takeda Pharmaceuticals Ltd. Business Overview
7.10.3 Takeda Pharmaceuticals Ltd. Subcutaneous Biologics Major Product Offerings
7.10.4 Takeda Pharmaceuticals Ltd. Subcutaneous Biologics Revenue in Global Market (2017-2022)
7.10.5 Takeda Pharmaceuticals Ltd. Key News
7.11 Alnylam Pharmaceuticals
7.11.1 Alnylam Pharmaceuticals Corporate Summary
7.11.2 Alnylam Pharmaceuticals Business Overview
7.11.3 Alnylam Pharmaceuticals Subcutaneous Biologics Major Product Offerings
7.11.4 Alnylam Pharmaceuticals Subcutaneous Biologics Revenue in Global Market (2017-2022)
7.11.5 Alnylam Pharmaceuticals Key News
7.12 Bayer AG
7.12.1 Bayer AG Corporate Summary
7.12.2 Bayer AG Business Overview
7.12.3 Bayer AG Subcutaneous Biologics Major Product Offerings
7.12.4 Bayer AG Subcutaneous Biologics Revenue in Global Market (2017-2022)
7.12.5 Bayer AG Key News
7.13 GlaxoSmithKline
7.13.1 GlaxoSmithKline Corporate Summary
7.13.2 GlaxoSmithKline Business Overview
7.13.3 GlaxoSmithKline Subcutaneous Biologics Major Product Offerings
7.13.4 GlaxoSmithKline Subcutaneous Biologics Revenue in Global Market (2017-2022)
7.13.5 GlaxoSmithKline Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer